Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis

Objective The prognosis of the patients who relapsed after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is poor, and therapeutic options are limited. In the present study, we investigated the efficacy and factors associated with the survival in patients with acute leukemia or myelo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2024/01/15, Vol.63(2), pp.197-205
Hauptverfasser:	Ogasawara, Masahiro, Nozu, Rintaro, Miki, Kosuke, Sugimura, Shunnsuke, Kojima, Keisuke, Hidaka, Daisuke, Ogasawara, Reiki, Okada, Kohei, Sugita, Junichi, Kobayashi, Naoki, Imamura, Masahiro, Ota, Shuichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease allogeneic hematopoietic stem cell transplantation Allografts Azacytidine CD3 antigen Chemotherapy Chronic Disease Cytogenetics donor lymphocyte infusion Graft versus host disease Graft vs Host Disease - etiology Graft-versus-host reaction graft-versus-leukemia effect Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Hematopoietic stem cells Humans Leukemia Leukemia, Myeloid, Acute - complications Leukemia, Myeloid, Acute - therapy Lymphocytes Lymphocytes T Medical prognosis Myelodysplastic syndrome Myelodysplastic syndromes Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - therapy Original Pathologic Complete Response Recurrence relapse Remission Retrospective Studies Stem cell transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!